Cardiotoxicity evaluation using human embryonic stem cells and induced pluripotent stem cell-derived cardiomyocytes
Open Access
- 9 March 2017
- journal article
- research article
- Published by Springer Nature in Stem Cell Research & Therapy
- Vol. 8 (1) , 1-7
Abstract
Cardiotoxicity remains an important concern in drug discovery. Human pluripotent stem cell-derived cardiomyocytes (hPSC-CMs) have become an attractive platform to evaluate cardiotoxicity. However, the consistency between human embryonic stem cell-derived cardiomyocytes (hESC-CMs) and human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) in prediction of cardiotoxicity has yet to be elucidated. Here we screened the toxicities of four representative drugs (E-4031, isoprenaline, quinidine, and haloperidol) using both hESC-CMs and hiPSC-CMs, combined with an impedance-based bioanalytical method. It showed that both hESC-CMs and hiPSC-CMs can recapitulate cardiotoxicity and identify the effects of well-characterized compounds. The combined platform of hPSC-CMs and an impedance-based bioanalytical method could improve preclinical cardiotoxicity screening, holding great potential for increasing drug development accuracy.Keywords
Funding Information
- National Foundation of Science and Technology (2012ZX09302002)
This publication has 22 references indexed in Scilit:
- High-Throughput Multi-Parameter Profiling of Electrophysiological Drug Effects in Human Embryonic Stem Cell Derived Cardiomyocytes Using Multi-Electrode ArraysToxicological Sciences, 2014
- Functional Cardiotoxicity Profiling and Screening Using the xCELLigence RTCA Cardio SystemSLAS Technology, 2011
- Cardiomyocytes derived from human embryonic and induced pluripotent stem cells: comparative ultrastructureJournal of Cellular and Molecular Medicine, 2011
- Cardiotoxicity testing using pluripotent stem cell‐derived human cardiomyocytes and state‐of‐the‐art bioanalytics: a reviewJournal of Applied Toxicology, 2011
- Modelling the long QT syndrome with induced pluripotent stem cellsNature, 2011
- Patient-Specific Induced Pluripotent Stem-Cell Models for Long-QT SyndromeNew England Journal of Medicine, 2010
- Effect of haloperidol on transient outward potassium current in rat ventricular myocytesEuropean Journal of Pharmacology, 2006
- The impact of drug-induced QT interval prolongation on drug discovery and developmentNature Reviews Drug Discovery, 2003
- The Association Between Intravenous Haloperidol and Torsades de PointesPsychosomatics, 1995
- Torsades de Pointes Ventricular Tachyarrhythmia Associated with HaloperidolJournal of Clinical Psychopharmacology, 1986